Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2010-9-17
pubmed:abstractText
Severe toxicity to 5-fluorouracil (5-FU) based chemotherapy in gastrointestinal cancer has been associated with constitutional genetic alterations of the dihydropyrimidine dehydrogenase gene (DPYD).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1471-2407
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
470
pubmed:meshHeading
pubmed-meshheading:20809970-Adenocarcinoma, pubmed-meshheading:20809970-Adult, pubmed-meshheading:20809970-Aged, pubmed-meshheading:20809970-Anemia, pubmed-meshheading:20809970-Antimetabolites, Antineoplastic, pubmed-meshheading:20809970-Carcinoma, Squamous Cell, pubmed-meshheading:20809970-Cross-Sectional Studies, pubmed-meshheading:20809970-DNA, Neoplasm, pubmed-meshheading:20809970-DNA Methylation, pubmed-meshheading:20809970-Dihydrouracil Dehydrogenase (NADP), pubmed-meshheading:20809970-Female, pubmed-meshheading:20809970-Fluorouracil, pubmed-meshheading:20809970-Gastrointestinal Neoplasms, pubmed-meshheading:20809970-Gene Rearrangement, pubmed-meshheading:20809970-Humans, pubmed-meshheading:20809970-Introns, pubmed-meshheading:20809970-Male, pubmed-meshheading:20809970-Middle Aged, pubmed-meshheading:20809970-Mucositis, pubmed-meshheading:20809970-Mutation, pubmed-meshheading:20809970-Neoplasm Staging, pubmed-meshheading:20809970-Neutropenia, pubmed-meshheading:20809970-Polymerase Chain Reaction, pubmed-meshheading:20809970-Prognosis, pubmed-meshheading:20809970-Promoter Regions, Genetic, pubmed-meshheading:20809970-Survival Rate, pubmed-meshheading:20809970-Thrombocytopenia
pubmed:year
2010
pubmed:articleTitle
Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients.
pubmed:affiliation
Department of Medical Oncology, Portuguese Oncology Institute - Porto, Portugal.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't